Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
2027-A COMPARATIVE EFFICACY OF FIBROSIS-4, LIVER STIFFNESS MEASUREMENT, AND FIBROSCAN-AST SCORE TO PREDICT MAJOR LIVER-RELATED OUTCOMES IN NON-ALCOHOLIC FATTY LIVER DISEASE: AN INTERNATIONAL MULTICENTER STUDY Yu JUN Wong 1,2 , Esteban Urias 3 , Michael W Song 4 , Tanvi Goyal 3 , Wei Xuan Tay 5 , Nicole Xinrong Han 5 , Jing Hong Loo 5 , Tian Yu Qiu 5 , Majd Aboona 6 , Claire Faulkner 6 , Karn Wijarnpreecha 7 , Yiong Huak Chan 8 and Vincent Chen 9 , (1)Department of Gastroenterology & Hepatology, Changi General Hospital, (2)Duke-Nus Medical School, Singhealth, (3)University of Michigan, (4)University of Michigan, Ann Arbor, (5)Changi General Hospital, (6)University of Arizona College of Medicine, Phoenix, AZ, (7)University of Arizona College of Medicine Phoenix, Phoenix, AZ, (8)Yong Loo Lin School of Medicine, National University of Singapore, Singapore, (9)University of Michigan Medical Center Background: Non-invasive tests (NITs) such as FIB-4, liver stiffness measurement (LSM) by vibration controlled transient elastography (VCTE), and FibroscanAST (FAST) are frequently used for risk stratification in non-alcoholic fatty liver disease
Pwosesis sa a degaje karnitin gratis, ki ka retounen nan sitoplasm pou patisipe nan pwochen wonn transp a
Data sharing statement : The data is presently unavailable in the public domain because the authors do not have permission to share data yet
Malatesta M, Fornasier E, Di Salvo ML, Tramonti A, Zangelmi E, Peracchi A, et al
Gently massage it onto damp skin in circular motions, focusing on rough areas like elbows, knees, or dry patches
Striatal dopamine release in schizophrenia comorbid with substance dependence
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
